The global metastatic cancer treatment market is projected to be worth USD 111.16 Billion by 2027, according to a current analysis by Emergen Research. The metastatic cancer treatment systems market is observing high demand attributed to the increasing incidence of cancer. The disease significantly impacts the societal and economic growth in the US and worldwide and is a major contributor to the cost burden of disease. It has been anticipated that 1,806,590 new cancer cases are likely to be diagnosed in the US in 2020, and 606,520 deaths will occur owing to the disease.
Growing technological advancements and increased investments in imaging technologies are causative of the rapid growth of the metastatic cancer treatment market. Hologic, Inc., in November 2019, received approval from the US Food and Drug Administration (FDA) for its 3DQuorum™ Imaging Technology, driven by Genius AI™. The technology works simultaneously with Hologic’s Clarity HD™ high-resolution imaging technology and helps radiologists reduce tomosynthesis image volume by 66.0%. The breast imaging system owing to such advancements would produce higher-resolution 3D images, better workflow, and an improved mammography experience for patents.
Based on the types, the metastatic cancer treatment market has been further classified based on geography, application and consumption capability. On the basis of the product application, the industry is bifurcated taking into consideration those in demand and are an outcome of technology advancement. Region-wise, the performance of the industry along with the prominent vendors operating in the geography also illuminates stakeholders, business owners, and field marketing, executives. The different facets of the business based on parameters including new launches, acquisition and mergers and new entrants are discussed extensively during the study.
Read more@ https://www.emergenresearch.com/industry-report/metastatic-cancer-treatment-market
Key Highlights From The Report
In September 2020, Bayer signed a worldwide license contract with Systems Oncology, LLC, for ERSO™, used in the pre-clinical development phase for metastatic breast cancer (ER-positive).
Lung cancer is a common type of cancer in men and the third-leading cancer type in women with 2 million novel cases in the year 2018. Hungary, Serbia, and New Caledonia (France) were the top three countries with the highest disease rate in 2018.
Specialty clinics are equipped with the requisite radiotherapy instrument devices and specialist staff to assist in disease diagnosis and adopting a suitable procedure for metastatic cancer treatment.
The metastatic cancer treatment market in the North American region held the largest market share in 2019, owing to the high adoption of advanced treatment technologies, a rising incidence of cancer, established healthcare infrastructure, and undertaking of various initiatives to create awareness about the disease.
Key participants include Bayer AG, Johnson Johnson, AstraZeneca PLC, Pfizer Inc., Bristol Myers Squibb Company, F. Hoffmann-La Roche AG, Amgen Inc., Merck Co. Inc., AbbVie Inc., and Novartis AG, among others.
Request For Free Sample@ https://www.emergenresearch.com/request-sample/329
Treatment Type Outlook (Revenue, USD Billion; 2017-2027)
Chemotherapy
Hormone Therapy
Immunotherapy
Others
Application Outlook (Revenue, USD Billion; 2017-2027)
Breast Cancer
Lung Cancer
Melanoma
Prostate Cancer
Colorectal Cancer
Others
End Users Outlook (Revenue, USD Billion; 2017-2027)
Hospital
Clinics
Research Institutes
Others
Regional Outlook (Revenue, USD Billion; 2017-2027)
North America
Europe
Asia Pacific
Latin America
MEA
Table of Content
Chapter 1. Methodology Sources
1.1. Metastatic Cancer Treatment Market Definition
1.2. Metastatic Cancer Treatment Market Research Scope
1.3. Metastatic Cancer Treatment Market Methodology
1.4. Metastatic Cancer Treatment Market Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Metastatic Cancer Treatment Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Metastatic Cancer Treatment Market Segmentation Impact Analysis
Continued…
Find similar reports by Emergen Research:
Soil Stabilization Market By Application (Agriculture, Industrial, Non-Agriculture), By Method (Chemical, Mechanical), By Additive (Mineral Stabilizing agents, Polymers), Forecasts to 2027
Drip Irrigation Market By Application (Subsurface drip irrigation, Surface drip irrigation), By Crop Type (Vegetable Crops, Field Crops, Vineyards, Orchard Crops), By Component (Emitters, Drip Tubes, Pressure Pumps, Filters, Valves), Forecasts to 2027
Target Drones Market By Payload (Camera, Control Systems, Tracking Systems, Others), By End-Users (Military, Commercial), By Price Range (Budget, Medium, Premium), and Regions Forecasts to 2027
Multi-Rotor Drone Market By Payload (Camera, Control Systems, Tracking Systems, Others), By End-Users (Military, Commercial), By Price Range (Budget, Medium, Premium), and Regions Forecasts to 2027
Plastic Adhesives Market By Resin Type (Epoxy, Polyurethane, Acrylic, Silicone, Cyanoacrylate, Methyl Methacrylate, and Others), By Substrate (Polyethylene, Polypropylene, Polyvinyl Chloride, and Others), By Distribution Channel (Online and Offline), By Application (Packaging, Building Construction, Automotive Transportation, Assembly, Medical, and Others), Forecasts to 2027
About Emergen Research
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us: Eric Lee (Corporate Sales Specialist)
Emergen Research | Web: https://www.emergenresearch.com
E-mail: [email protected]
